Vertex Pharmaceuticals
31 декабря 2017, 17:39

Лучшие акции 2017 года: Boeing, PayPal, Vertex Pharmaceuticals

Это был еще один знаковый год для фондового рынка, который в 2017 году достиг рекордных высот с головокружительной скоростью: вторая в истории по продолжительности гонка на повышение продолжается.

27 декабря 2017, 15:04

Biotech Stock Roundup: BIIB, CELG Hit by Pipeline News, Acquisition Deals for Ignyta, Sucampo

A couple of acquisition agreements as well as pipeline news from Celgene (CELG) and Biogen were the key highlights this week in the biotech sector.

Выбор редакции
22 декабря 2017, 15:00

The Best Stocks Of 2017: Boeing, PayPal, Vertex Pharmaceuticals

Here are the biggest winners of a relentless bull market:

20 декабря 2017, 14:30

Biotech Stock Roundup: Label Expansion for Exelixis's Cabometyx, FDA Nod for Spark's Gene Therapy

A one-time gene therapy for an inherited retinal disease gained FDA approval this week while Exelixis's (EXEL) Cabometyx can now be used in treatment-naive advanced renal cell carcinoma patients.

19 декабря 2017, 17:57

5 Hot Stocks Driving the Nasdaq ETF Rally

Inside the top performing stocks of the Nasdaq ETF.

13 декабря 2017, 17:24

Proteostasis Stock Surges on Positive Data From CF Studies

Proteostasis (PTI) stock skyrockets on positive results from early and mid-stage studies on its cystic fibrosis pipeline candidates.

13 декабря 2017, 15:38

Biotech Stock Roundup: ASH Data in Focus, Gilead to Buy Cell Design Labs

The annual meeting of the American Society of Hematology was the key highlight this week with several companies like bluebird (BLUE) presenting data on their investigational treatments.

13 декабря 2017, 13:19

The missing Alzheimer's pill

When it comes to some of the biggest diseases America faces in the future, our drug system is set up to fail. What needs to happen?

11 декабря 2017, 16:20

4 Drug/Biotech Stocks That Could Be Buyout Targets in 2018

Biotech mergers and acquisitions, which were quite lean in 2017, may pick up significantly in 2018 if the proposed tax reforms are finally approved.

08 декабря 2017, 19:51

Vertex Kalydeco Study Successful in Children Aged 1-2 Years

Vertex Pharmaceuticals' (VRTX) phase III study evaluating Kalydeco in children as young as one year meets its primary safety endpoint.

28 ноября 2017, 23:15

New Pharma ETF PILL : What Investors Need to Know

Inside the pros and cons of the pharma sector and chances of outperformance of the just-launched fund PILL.

28 ноября 2017, 14:31

The Zacks Analyst Blog Highlights: Starbucks, NIKE, Manulife, Intuit and Vertex

The Zacks Analyst Blog Highlights: Starbucks, NIKE, Manulife, Intuit and Vertex

28 ноября 2017, 00:10

Top Analyst Reports for Starbucks, NIKE & Manulife

Top Analyst Reports for Starbucks, NIKE & Manulife

20 ноября 2017, 17:44

Galapagos' CF Candidate Shows Potential in Phase II Study

Galapagos' (GLPG) CFTR corrector candidate, GLPG2222, shows potential in a phase II study on CF patients.

17 ноября 2017, 15:09

Biotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3

After rising 15.4% in the first nine months of the year, the Medical-Biotech /Genetics industry has declined 13.4% so far in the fourth quarter.

15 ноября 2017, 16:16

Biotech Stock Roundup: Dynavax Vaccine Gets FDA Nod, Loxo Inks Deal with Bayer

Regulatory actions and licensing and collaboration agreements were the key highlights this week with companies like Loxo Oncology (LOXO) remaining in the limelight.

13 ноября 2017, 22:20

Vertex Gets CHMP Recommendation for Orkambi Label Expansion

Vertex (VRTX) received CHMP recommendation for label expansion of Orkambi in children aged 6 to 11 years with CF who have two copies of the F508del mutation.

09 ноября 2017, 16:28

Biotech Stock Roundup: Regeneron Delivers Strong Q3 Results, Cellectis Clinical Hold Lifted

While focus remained on Regeneron's (REGN) Q3 earnings, Dicerna was also in the news related to its collaboration agreement with Boehringer Ingelheim.

01 ноября 2017, 16:24

Biotech Stock Roundup: Celgene, Amgen, Gilead Hit by Q3 Results, Vertex Beats on All Fronts

It was all about earnings this week with major biotech companies like Gilead (GILD), Celgene and Amgen reporting third quarter results.

26 октября 2017, 18:51

Vertex (VRTX) Beats on Q3 Earnings & Sales, Raises 2017 View

Vertex Pharma (VRTX) third-quarter earnings increased from the year-ago period led by strong sales of CF drugs.